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S~mlnal"y 
Crosslinking of the low affinity immunoglobulin G (IgG) Fc receptor (Fc"/K type III) on natural 
killer (NK) cells initiates antibody-dependent cellular cytotoxicity.  During this process, FcyR 
stimulation results in the rapid activation of phospholipase C (PLC), which hydrolyzes membrane 
phosphoinositides,  generating inositol-l,4,5-trisphosphate and sn-l,2-diacylglycerol  as second 
messengers. We have recently reported that PLC activation after FcyR stimulation can be inhibited 
by a protein tyrosine kinase (PTK) inhibitor.  Based on the paradigm provided by the receptor 
tyrosine kinases, we investigated whether PLC-3,1 and/or PLC-'y2 are expressed in NK cells, 
and whether the PLC-y isoforms are tyrosine phosphorylated in response to Fc',/R stimulation. 
Immunoblotting analyses with PLC-',/1- and PLC-y2-specific  antisera demonstrate that both 
isoforms are expressed in human NK cells. Furthermore, FcyR crosslinking triggers the tyrosine 
phosphorylation of both PLC-'y1 and PLC-3~2 in these cells. Phosphorylation of both isoforms 
is detectable within 1 min, and returns to basal level within 30 min. Pretreatment with herbimycin 
A, a PTK inhibitor, blocked the FcyK-induced tyrosine phosphorylation of PLC-3,1 and PLC-3,2, 
and the subsequent  release of inositol  phosphates.  These results  suggest  that Fc'yR-initiated 
phosphoinositide turnover in human NK cells is regulated by the tyrosine phosphorylation of 
PLC-3'. More broadly,  these observations  demonstrate that nonreceptor PTK(s)  activated by 
crosslinkage of a multisubunit receptor  can phosphorylate both PLC-'y isoforms. 
T 
he presence of foreign antigens  in an immunocompe- 
tent host elicits the generation of antigen-specific anti- 
bodies. The binding of these antibodies  to antigen-bearing 
cells marks them for subsequent destruction by various im- 
mune effector cells, including NK cells. NK cells represent 
a distinct subpopulation of lymphocytes that expresses low 
affinity receptors for IgG (FcyR type III) on their surfaces 
(1). The binding of FcyR type M  (hereafter referred to as 
FcyK) to its ligand, the Fc portion of IgG antibodies present 
on the target cell's surface, initiates a cascade of intracellular 
biochemical signals in the NK cells that ultimately leads to 
the exocytosis of preformed cytolytic granules  (2-4).  Our 
group and others have characterized proximal signal trans- 
duction events initiated by FeyR activation in NK cells (for 
reviews see references 5, 6) and have shown that FcyK cross- 
linking results in the rapid induction of phosphoinositide- 
specific phospholipase  C  (PLC) activity (7). The activated 
PLC  hydrolyzes  membrane  phosphatidylinositol-4,5- 
bisphosphate  into  inositol-l,4,5-trisphosphate  and sn-l,2- 
diacylglycerol, which, in turn, mediate the mobilization of 
intracellular calcium and the activation of protein kinase C, 
respectively (8). Experiments with calcium ionophores  and 
phorbol esters (1, 5, 6, 9) suggest critical roles for PLC-derived 
second messengers in the development of antibody-dependent 
cellular cytotoxicity. However, the mechanism that couples 
Fc"/R stimulation to PLC activation  remains unknown. 
Transmembrane receptors can be coupled to PLC either 
via heterotrimeric G proteins or protein tyrosine kinases (FrK) 
(for reviews see references 10-12). For example, receptors with 
seven transmembrane regions  such  as  the ml  muscarinic 
receptor can utilize Gq/11 to activate the PLC-B family (13). 
In contrast,  growth factor receptors with intrinsic PTK ac- 
tivity, such as the epidermal growth factor (EGF) and platelet- 
derived growth factor (PDGF) receptors, can directly tyro- 
sine phosphorylate  members of the PLC-3, family (14-16). 
More recently, activation of the TCR, which does not con- 
tain an intrinsic PTK domain, has also been shown to induce 
the tyrosine phosphorylation of PLC-'y1 (17-19). 
Using exogenous guanine nucleotides and permeabilized 
NK cells, we have recently demonstrated that the Fc'yR-PLC 
coupling does not involve a G protein (20). However,  the 
FIX inhibitor, herbimycin A, inhibits the Fc"/R-induced PLC 
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PLC coupling  (20).  In  this  study,  we investigated  which 
members of the PLC-~/family are expressed in human NK 
cells, and whether any of these are tyrosine phosphorylated 
after Fc~tL stimulation.  Our initial characterization  of the 
PLC-3~ family in NK cells showed that both isoforms, PLC-~/1 
and PLC-'y2, were expressed. Subsequent experiments demon- 
strated that cross[inking  of the Fear rapidly induced the tyro- 
sine phosphorylation of both PLCw isoforms. Finally, pretreat- 
ment of NK cells with  the PTK inhibitor,  herbimycin A, 
blocked  both  Fc'yR-induced  tyrosine  phosphorylation  of 
PLC-qr and the receptor-mediated increase in inositol phos- 
phate formation.  Thus,  our results demonstrate  that  both 
PLC-~/1  and PLC-'y2 are expressed in human NK cells and 
strongly  suggest  that  these isoforms participate  in  FcTR- 
induced phosphoinositide  hydrolysis. 
Materials and Methods 
Cell Lines.  Human CD16 § NK cell lines were isolated and 
passaged as previously described (7). The cell surface phenotype 
of these NK cell lines was monitored by flow cytometry. All donal 
NK cell lines used in these studies were 100% CD16+/CD3-; 
polyclonal cell lines were >90% CD16 +  . In addition,  all CD16 + 
NK ceils expressed the following additional phenotypic markers: 
CD56 §  CDllb +, CD2 +, and HLA-DR +. The human leukemic 
T cell line, Jurkat, was obtained from the American Type Culture 
Collection (ILockviile, MD), and PJL-EBV is an EBV-transformed 
human B cell line. 
Chemical Reagents and Antibodies.  The  PTK inhibitor,  her- 
bimycin A, was generously provided by Dr. Y. Uehara (Depart- 
ment of Antibiotics,  National Institute  of Health, Tokyo, Japan). 
All other chemicals and drugs, unless otherwise noted, were ob- 
tained from Sigma Chemical Co. (St. Louis, MO). Fluorescein and 
PE-conjugated mAb were obtained from Becton Dickinson Mono- 
donal Center (Mountain View, CA). PI.C-'yl antisera was obtained 
by immunizing  New Zealand White rabbits with a PLC-'yl pep- 
tide (bovine PI,  C-')'I  amino acid 1249-1262) chemically coupled 
to KLH (Calbiochem  Corp.,  La Jolla,  CA) by a m-maleimido- 
benzoyl-N-hydoxysuccinimide ester (Pierce Chemical Co., Rock- 
ford, IL). Similarly, PLC-3,2 antisera was obtained by immunizing 
New Zealand White rabbits with a KLH-coupled PLC-~/2 peptide 
(human PLC-3~2 amino acid 461--481). The anti-PLC-3,1 and anti- 
PLC-~/2 sera immunoprecipitated  the predicted 150- and 140-kD 
molecular mass isoforms, respectively. Furthermore,  anti-PLC-3,1 
or anti-PLC-3,2 immunoprecipitated protein was detectable by im- 
munoblotting with the same antiserum, but not by the antiserum 
to the other isoform. 
PLC'lmmunoblotting.  5-10  x  10  ~ ceils were washed, pelleted, 
and lysed with buffer containing  10 mM Tris-HC1, 50 mM NaC1, 
5 mM EDTA, 50 mM NaP, 30 mM Na4PaOT, 1 mM PMSF, 5 
/zg/ml aprotinin, 10/zg/rrd leupeptin, and 1% Triton X-100, pH 7.4. 
Insoluble material was removed by centrifugation  at 15,000 g for 
15 rain, and the protein content of the detergent-soluble fraction 
determined by the bicinchoninic acid (BCA) protein assay (Pierce 
Chemical Co., Rockford, IL) according to the manufacturer's in- 
stractions.  Protein  (150/zg)  was then resolved by discontinuous 
SDS-PAGE in 8.5% acrylamide gels and electrophoretically trans- 
ferred to a nitroceUulose membrane. The membrane was blocked 
overnight in Tris-buffered saline (TBS) (50 mM Tris-HC1, 150 mM 
NaCI, pH 7.4) containing 2% milk and 0.2% polyoxyethylene sor- 
bitan monolanrate  (Tween 20) and incubated for 1 h with PLC- 
3'1- or PLC-3'2-specific antiserum  (1:2000 dilution  of anti-PLC- 
34 or 1:400 dilution of anti-PLC-'y2) in TBS containing 2% BSA, 
0.2% Tween 20, and 0.05% NAN3. After three washes with 0.2% 
Tween 20 in TBS, immunoreactive  proteins  were detected with 
protein A-horseradish peroxidase and the enhanced chemilumines- 
cence  (ECL)  detection  system  (Amersham  Corp.,  Arlington 
Heights,  IL). 
PLC-~/ Immunoprecipitation and Antiphosphotyrosine  Immunoblot- 
ring.  Aliquots of NK ceils (2-4  x  107Aample) were resuspendcd 
in 200/zl of HBSS containing 10 mM Hepes, pH 7.2, and I mg/ml 
BSA. Ceils were stimulated by adding 50/zl of anti-Fc'yRIII mAb 
(3G8) (final concentration,  10/~g/ml)  and goat F(ab')z fragment 
anti-mouse IgG (Organon Teknika Corp., West Chester, PA). After 
the indicated time, reactions were terminated by the addition of 
4 volumes of ice-cold lysis buffer containing 20 mM Tris-HC1, 40 
mM NaC1, 5 mM EDr_A, 50 mM NaF, 30 mM Na4P2OT, and 500 
/~M  Na3VO4,  1  mM  PMSF,  5  /~g/ml aprotinin,  10  /zg/ml 
leupeptin,  and 1% Triton X-100, pH 7.4. After  10 rain at 4~ 
the samples were centrifuged (15,000 g, 15 rain) to remove nuclear 
and cellular debris. Postnuclear supernatants were immunoprecipi- 
tared for 2 h at 4~  with PLC-3,1- or PLC-~/2-specific antisera 
bound to protein A-Sepharose beads. The immunoprecipitates were 
washed three times, bound proteins eluted with 50/zl of SDS sample 
buffer, and resolved by SDS-PAGE as described above. The pro- 
teins were electrophoreticaLly transferred to nitrocellulose mem- 
branes and antiphosphotyrosinc  immunoblotting was performed 
essentially as previously described (20). Briefly, nitrocellulose mem- 
branes were blocked overnight in TBS containing 4% BSA, 0.5% 
Tween 20 and 0.05% NAN3, and were then probed for 2 h with 
antiphosphotyrosine mAb 4G10 (Upstate Biotechnology, Inc., Lake 
Placid, NY) (1/~g/ml in TBS with 0.5% Tween 20). The mem- 
branes were washed three times with 0.2% Tween 20 in TBS, and 
incubated for 45 rain with rabbit  anti-mouse IgG (H  +  L) (1 
/zg/ml) (Pierce Chemical Co.) in TBS containing 2% BSA and 0.5% 
Tween 20. After three washes, immunoreactive proteins were de- 
tected with protein A-horseradish peroxidase and the ECL detec- 
tion system from Amersham  Corp. 
Results and Discussion 
Expression of  PLC.  7 Isoforms in Human NK Cells.  We first 
examined whether PLC-3~I and/or its dosdy related isoform, 
PI.C-v2,  are expressed  in  human  NK cells.  Fig.  1 shows 
PLC-34  and PLC-~/2  immunoblots  of equivalent  amounts 
of detergent-soluble proteins from Jurkat cells (a human leu- 
kemic T cell line), EBV-transformed  human B cells (PJL-EBV), 
and three different donal human NK cell lines.  Consistent 
with prior reports (17-19,  21), Jurkat  cells expressed rda- 
tively high levels of PLC-3~I, migrating at an apparent mo- 
lecular mass of 150 kD (Fig.  1 A, lane 1). The PLC-3'I an- 
tiserum also detected the presence of PLC-'y1 in the three 
human NK clones (Fig.  1 A, lanes 3-5), albeit at lower levels 
than Jurkat.  The same blot was stripped and reprobed with 
the PLC-'y2 antiserum (Fig. 1 B). Consistent with prior reports 
(22-24), rdativdy high levels of PLC-3'2 (migrating at 140 
kD) were detected in EBV-transformed human B cells (Fig. 
1 B, lane 2),  whereas little PLC-3,2 was present  in Jurkat 
(Fig.  1 B, lane I).  In each of the NK cell lines,  significant 
amounts of PLC-'y2 were detected (Fig. 1 B, lanes 3-5). Our 
data suggest that both PLC-3~I and PLC-3,2 are present in 
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and PLC-3,2 isoforms. Detergent- 
soluble protein (150/zg) from the 
human leukemic T cell line, Jurkat 
(lane 1), EBV-transformed human 
B cells (lane 2), and three different 
human NK clones (lanes 3-5) were 
resolved  by SDS-PAGE,  transferred 
to nitrocellulose, and probed with 
a PLC-q,l-specific  antiserum (A) 
as  described  in  Materials  and 
Methods. The same blot was then 
stripped using a 5 M sodium io- 
dide and I  mM sodium t[iiosul- 
phate solution, and reprobed with 
a PLC-q,2-specific antiserum (B). 
The  molecular mass  calibration 
standards  shown on the left are 
200,  116, and  96  kD  (top  to 
bottom). 
human NK cells, with PLC-3,2 being the more prominent 
immunoreactive isoform. 
FcyR  Crosslinking Induces the Tyrosine Phosphorylation of 
PLC-71 and PLC-~,2.  We next investigated whether PLC-3,1 
and PLC-3,2 are direct substrates for Fc3,R-induced tyrosine 
phosphorylation. NK ceUs were stimulated with crosslinked 
anti-Fc3,R mAb (3G8), and then either PLC-'),I or PLC-'),2 
was immunoprecipitated with their respective antiserum. The 
immunoprecipitates were separated  by SDS-PAGE, transferred 
to  nitrocellulose,  and immunoblotted with the  antiphos- 
photyrosine mAb, 4G10. As shown in Fig. 2, FcTR cross- 
linkage resulted  in a rapid increase in the phosphotyrosine 
contents of both PLC-'),I and PLC-72. Kinetic analyses indi- 
cated that tyrosine phosphorylation of both isoforms followed 
a similar time course, being detectable within 1 min after 
stimulation,  remaining elevated for  at  least  10  rain,  and 
returning to basal level by 30 rain (Fig. 2). Reanalyses of the 
nitrocellulose with the antiserum specific  for each PLC-3, iso- 
form indicated that the kinetic changes were not due to Fc'yR- 
induced alterations in the level of PLC protein expression. 
Sultzman et al. (25) have reported that in Rat-2 fibroblasts 
transfected with PLC-3'2, PDGF stimulation resulted in the 
tyrosine phosphorylation of both PLC-3,1 and PLC-3,2. Our 
data extend that study by demonstrating that in a cell type 
that endogenously expresses both PI.C-3'I and PLC-3,2, non- 
receptor PTK(s) activated by crosslinkage of a multisubunit 
receptor  can phosphorylate both PLC-~ isoforms. 
Herbimycin A Inhibits  Fc~,R-induced  Tyrosine  Phosphorylation 
of PLC.-  7.  To examine further the notion that the PTK- 
mediated phosphorylation of both PLC-'), is a critical event 
in FcyR-induced activation  of PLC, we tested the effect of 
herbimycin A, a PTK inhibitor (26), on the Fc'yR-induced 
tyrosine phosphorylation of the PLC-'), isoforms. NK cells 
were treated with herbimycin A under conditions that we 
have previously shown to inhibit tyrosine phosphorylation 
and phosphoinositide hydrolysis  in NK cells (3 #M herbimycin 
A for 16 h) (20, 27). These same condition leave intact other 
protein kinase-dependent  cellular responses such as the phorbol 
ester-induced  phosphorylation of p56 ~  (20,  27). Pretreat- 
ment with herbimycin A effectively  blocked the FeyR-induced 
tyrosine phosphorylation of both PLC-3'I (data not shown) 
and PLC-'y2 (Fig. 3). These results are consistent with a model 
in which FcTR stimulation in NK cells rapidly activates an 
intracellular PTK, which, in turn, induces the tyrosine phos- 
phorylation and activation  of PLC-% 
Although none of the identified components of the multi- 
meric FcTR complex have been shown to possess intrinsic 
PTK activity, the FcTR must be associated with an intracel- 
Figure 2.  Kinetics ofFc~R-induced tyrosine phosphorylation of PLC-3,1 
and PLC-3,2 in NK cells. Polyclonal NK cells (3.5-4  x  107 per sample) 
were stimulated with cross[inked anti-Fc'),R mAb (3G8) for the indicated 
times.  Anti-PI.C-')'l (.4)  or anti-PLC-3/2  (/3) immunoprecipitates were 
resolved by SDS-PAGE and transferred to nitrocellulose.  (/1) The nitrocel- 
lulose was sequentially probed with antiphosphotyrosine antibody (top), 
and after stripping, with the PLC-'y1 antiserum (bottom).  (B) The mem- 
brane was sequentially probed with antiphosphotyrosine antibody (top) 
and after stripping, with the PLC-'),2 antiserum (bottom).  The molecular 
mass standards  are 200 and 116 kD. 
Figure 3.  Herbimycin A inhibits the FcTR-induced tyrosine phosphory- 
lation of PI.C-3,2. NK cells were pretreated for 16 h either with (shaded 
bars) or without (hatched bars) 3/zM herbimycin A, and then stimulated 
for 1 rain with either media (control) or cross[inked anti-FcyR mAb (3G8). 
PLC-3,2 immunoprecipitates were immunoblotted with antiphosphotyrosine 
antibody as described  in Fig. 2. After detection of the immunoreactive 
protein with the ECL reagent, the developed films were subjected to den- 
sitometric analysis using the Image version  1.28 software (Wayne Ras- 
band, National Institutes of Health, Research Services Branch,  NIMH, 
Bethesda, MD) on a Macintosh lid (Cupertino, CA) and Hewlett-Packard 
ScanJet Plus (Sunnyvale,  CA). The levels  of tyrosine phosphoryhtion shown 
here are normalized to their respective  amount of PI-C-3,2 protein. 
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the src-family  (NK cells express  P56  ~,  p62~  s,  p59fy", and 
p56  ly~ [28]),  and other nonreceptor PTK, such as p72Sy  ~ (29) 
and PTK72 (30).  The information  provided in this report 
provides a foundation for evaluating the potential role of these 
intracellular PTK in the development of antibody-dependent 
cellular cytotoxicity. For example, it has become increasingly 
clear that the amino acid sequences of the SH2 domains of 
specific enzymes can directly influence their association with 
phosphotyrosine-containing  transmembrane or intracellular 
proteins (31). Since PLC-qrl and PLC-qr2 differ in their SH2 
domains,  these differences may dictate unique associations with 
specific PTK, and raise the possibility that PLC-~/1 and PLC- 
3'2 may be differentially regulated in lymphoid cells through 
either intermolecular  associations or phosphorylation. 
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